Val-de-Reuil is the largest manufacturing site producing influenza vaccines in the world and a worldwide distribution center for our vaccines portfolio.

City Crossing on July 06, 2024

Lisieux is a manufacturing site dedicated to the production of paracetamol-based medicines.

City Crossing on May 30, 2024

La Maison Sanofi, our global headquarters, reflects the modern healthcare company we strive to become: a company open to the world and that seeks to offer its people the best work environment to chase the miracles of science.

Stopover on August 28, 2024

Gentilly Campus gathers close to 3,000 Sanofians and is essential to our French and global operations. It’s strongly connected to its local community.

Stopover on July 21, 2024

Neuville is a manufacturing site that will soon inaugurate an “EVolutive Facility”. This factory of the future will enable more flexible manufacturing of vaccines and biomedicines while minimizing our impact on the environment.

Stopover on June 21, 2024

Montpellier is a leading site for our R&D operations, and a worldwide center of excellence for clinical trials supply chain. It is also at the fore regarding environmental sustainability.

Stopover on May 13, 2024